Athira Pharma transfers to Nasdaq Capital Market; must regain $1 bid price by Oct 13, 2025

LeonaBio, Inc.

Approved transfer from Nasdaq Global Select Market to Capital Market effective April 17, 2025.
Failed to meet $1 minimum bid price; granted 180-day grace period until October 13, 2025.
Must have bid price ≥ $1 for ten consecutive business days during grace period to regain compliance.
Seeking stockholder approval for reverse stock split at its 2025 annual meeting.
Stock continues trading under symbol 'ATHA' on Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.